Similar articles

• [Symposium on the diagnosis of diabetes mellitus. (4)-iv C-peptide assay and diagnosis of diabetes mellitus (author's transl)].

  Toyota T. Toyota T. Nihon Naika Gakkai Zasshi. 1977 Jan;66(1):49-54. doi: 10.2169/naika.66.49. Nihon Naika Gakkai Zasshi. 1977. PMID: 559036 Japanese. No abstract available.
• Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders.

  Rubenstein AH, Kuzuya H, Horwitz DL. Rubenstein AH, et al. Arch Intern Med. 1977 May;137(5):625-32. Arch Intern Med. 1977. PMID: 193451
• [Pancreatic B cell peptides: kinetic behaviour and concentrations of proinsulin, insulin and C-peptide in plasma and urine, problems of assay methods, clinical significance and literature review (author's transl)].

  Gerbitz KD. Gerbitz KD. J Clin Chem Clin Biochem. 1980 Jun;18(6):313-26. J Clin Chem Clin Biochem. 1980. PMID: 7000969 Review. German.
• [C peptide and its importance in diabetology].

  Dorner M, Brogard JM, Pinget M, Sapin R, Demangeat C, Comte F. Dorner M, et al. Journ Annu Diabetol Hotel Dieu. 1979:75-91. Journ Annu Diabetol Hotel Dieu. 1979. PMID: 502146 French. No abstract available.
• [C-peptide immunoreactivity CPR), urine CPR, beta-cell function (author's transl)].

  Teshirogi T. Teshirogi T. Nihon Ika Daigaku Zasshi. 1981 Jun;48(3):333-8. Nihon Ika Daigaku Zasshi. 1981. PMID: 7028779 Review. Japanese. No abstract available.